Humana (HUM) One Off US$644m Loss Tests Thin 0.9% Margin Narratives

Simply Wall St.04-30 09:21

Humana (HUM) has just opened 2026 earnings season with Q1 numbers that sit against a volatile prior year, where quarterly revenue moved from US$29.2b in Q4 2024 to US$32.5b in Q4 2025 while basic EPS ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2631721175?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/company-cover/29618-main-header/1756204961955","is_english":true,"pubTime":"2026-04-30 09:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2631721175","market":"nz","top_or_hot":-1,"title":"Humana (HUM) One Off US$644m Loss Tests Thin 0.9% Margin Narratives","media":"Simply Wall St.","content":"<div>\n<p>Humana (HUM) has just opened 2026 earnings season with Q1 numbers that sit against a volatile prior year, where quarterly revenue moved from US$29.2b in Q4 2024 to US$32.5b in Q4 2025 while basic EPS ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-hum/humana/news/humana-hum-one-off-us644m-loss-tests-thin-09-margin-narrativ\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Humana (HUM) One Off US$644m Loss Tests Thin 0.9% Margin Narratives</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHumana (HUM) One Off US$644m Loss Tests Thin 0.9% Margin Narratives\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-04-30 09:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-hum/humana/news/humana-hum-one-off-us644m-loss-tests-thin-09-margin-narrativ><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Humana (HUM) has just opened 2026 earnings season with Q1 numbers that sit against a volatile prior year, where quarterly revenue moved from US$29.2b in Q4 2024 to US$32.5b in Q4 2025 while basic EPS ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-hum/humana/news/humana-hum-one-off-us644m-loss-tests-thin-09-margin-narrativ\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1983260115.SGD","symbol_name":"Janus Henderson Horizon Global Sustainable Equity A2 SGD-H","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-hum/humana/news/humana-hum-one-off-us644m-loss-tests-thin-09-margin-narrativ","article_id":"2631721175","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/company-cover/29618-main-header/1756204961955"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-hum/humana/news/humana-hum-one-off-us644m-loss-tests-thin-09-margin-narrativ","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2631721175","pubTimestamp":1777512084,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Humana (HUM) has just opened 2026 earnings season with Q1 numbers that sit against a volatile prior year, where quarterly revenue moved from US$29.2b in Q4 2024 to US$32.5b in Q4 2025 while basic EPS swung from a loss of US$5.75 to a loss of US$6.61. Over that stretch, quarterly basic EPS ranged from US$10.31 in Q1 2025 down through US$4.52 in Q2 and US$1.62 in Q3 before ending the year in the red. This sets up a results narrative that focuses heavily on how consistently the business can...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU1983260115.SGD":"Janus Henderson Horizon Global Sustainable Equity A2 SGD-H","HUM":"哈门那","LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","LU0348723411.USD":"ALLIANZ GLOBAL HI-TECH GROWTH \"A\" (USD) INC","SG9999014005.SGD":"United Global Durable Equities Fund Acc SGD","SG9999014021.USD":"UNITED GLOBAL DURABLE EQUITIES (USDHDG) ACC","HUM.AU":"HUMM GROUP LTD","BK4585":"ETF&股票定投概念","SG9999014013.SGD":"United Global Durable Equities Fund Dis SGD","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","LU0238689110.USD":"贝莱德环球动力股票基金","BK7500":"支付概念","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","BK4566":"资本集团","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","LU0390134368.USD":"FRANKLIN GLOBAL GROWTH \"A\" (USD) ACC","LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC","BK7093":"消费信贷","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","BK4588":"碎股","BK4154":"管理型保健护理"},"translate_title":"Humana(HUM)一次性亏损6.44亿美元，利润率仅为0.9%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HUM":1,"HUM.AU":1.5},"content_text":"Humana (HUM) has just opened 2026 earnings season with Q1 numbers that sit against a volatile prior year, where quarterly revenue moved from US$29.2b in Q4 2024 to US$32.5b in Q4 2025 while basic EPS swung from a loss of US$5.75 to a loss of US$6.61. Over that stretch, quarterly basic EPS ranged from US$10.31 in Q1 2025 down through US$4.52 in Q2 and US$1.62 in Q3 before ending the year in the red. This sets up a results narrative that focuses heavily on how consistently the business can translate a large revenue base into sustainable profits and steadier margins. See our full analysis for Humana. With the headline figures on the table, the next step is to see how these results line up against the widely followed stories about Humana's growth potential, risk profile, and long term profitability. See what the community is saying about Humana NYSE:HUM Earnings & Revenue History as at Apr 2026 AdvertisementMargins Thin With 0.9% Net Profit  On a trailing 12 month basis, Humana generated US$129.7b of revenue and US$1.2b of net income, which works out to a 0.9% net profit margin compared with 1.0% the prior year. Consensus narrative expects margin support from better clinical quality and AI driven efficiency, yet the 0.9% margin and US$644.0m one off loss show how sensitive results still are:\n     Efforts like medication adherence campaigns and CenterWell growth are framed as helping margins. However, the thin 0.9% margin leaves limited room for error when medical costs move unexpectedly. The one off US$644.0m loss is a reminder that even with quality and efficiency efforts, large single items can materially affect reported profitability and mask the underlying run rate.    EPS Swings From US$10.31 To Losses  Across 2025, basic EPS went from US$10.31 in Q1 to US$4.52 in Q2, US$1.62 in Q3 and then a loss of US$6.61 in Q4, while quarterly revenue stayed in a relatively tight band around US$32.1b to US$32.6b. Bears focus on this kind of volatility, arguing that heavy reliance on Medicare Advantage and rising utilization could keep earnings bumpy:\n     The fact that EPS moved from double digit profit to a sizeable loss within the same year, despite revenue holding around US$32b each quarter, lines up with concerns about margin pressure when medical costs or reimbursement terms shift. With more than 80% of revenue tied to Medicare Advantage in the bearish narrative, these swings give numbers to the idea that changes to reimbursement or higher cost categories like oncology can quickly feed through to the bottom line.    Skeptics point to these earnings swings as evidence that regulatory shifts or higher medical costs could quickly hit Humana's bottom line, and they unpack that case further in the 🐻 Humana Bear Case DCF Fair Value Far Above US$243.12  Humana's share price sits around US$243.12, while a supplied DCF fair value of US$986.18 implies a gap of about 75.3%, and the trailing P/E of 24.6x is lower than the 32.5x peer average but slightly above the 24.3x US Healthcare industry average. Bullish investors argue that strong forecast earnings growth of 31.45% per year and this discount to DCF fair value frame a supportive setup:\n     The combination of a lower P/E than peers and a DCF fair value that is very large compared with the current price is used to argue that the market is not fully reflecting the earnings path implied by analyst forecasts. At the same time, the modest 6.2% forecast revenue growth and the recent 0.9% net margin give you a sense of why the market might be cautious, even as bulls highlight Medicare Advantage and CenterWell as long term growth drivers.    For a closer look at why some investors see that large DCF gap as an opportunity, and how they think about Medicare and CenterWell growth against these thin margins, check out the 🐂 Humana Bull Case Next Steps To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Humana on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves. Mixed signals in the numbers so far? Use the data, stress test your own thesis, and see how it lines up against our breakdown of 2 key rewards and 2 important warning signs. See What Else Is Out There Humana's thin 0.9% net margin, earnings swings from US$10.31 EPS to quarterly losses, and reliance on Medicare Advantage highlight how fragile profitability can be. If you want ideas with steadier earnings profiles and less earnings whiplash, check out 71 resilient stocks with low risk scores today and compare those businesses against Humana's recent volatility.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Humana might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2631721175","isCrawlerRequest":true}